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Vitamin D deficiency is prevalent in infants and children in the underdeveloped countries1. Infants with
mild deficiency tend to present with complications like hypocalcemic seizures whereas occurrence of
pathological features in advanced rickets is well elucidated2. Secondary myeloflbrosis has been
reported as a complication of severe rickets and in these children anemia, myeloid metaplasia and bone
marrow aplasia strongly suggested myelofibrosis. Despite the high prevalence of rickets in the Indo-
Pakistan subcontinent, there has been no report on this complication.We present a case of severe
clinical rickets who had developed secondary myelofibrosis with hepatosplenomegaly. The purpose of
presentation is to highlight this rare complication and increase clinician’s awareness. The pathogenesis
of myelofibrosis in rickets is discussed with emphasis on the reversible nature of the disease.
Case Report 
Eighteen months old girl, AK, was admitted to the Aga Khan University Hospital with cough and fever
for 3 weeks and breathlessness for 3 days prior to presentation. The child, born to healthy
consanguineous parents, had been suffering from recurrent bouts of fever and cough from the age of 5
months and was treated for reactive airway disease in her hometown. She had received all the primary
immunizations and there was no history of tuebrculosis in the family. The child’s motor milestones
were grossly delayed but her intellectual development was normal. The nutritional intake was very
poor, comprising of diluted buffalo milk and small quantities of home cooked cereals. The child
severely malnourished, weighing 4.2 kg and her length was 67 cms. She was anemic, had a widely
open anterior fontanelle and florid clinical rickets (figure 1).
Both wrists and ankles were very broad with double lateral malleoli, prominent rachitic rosary and
Hari-ison’s sulcus were present on the chest. The child had bilateral pneumonia and significant
hepatosplenomegaly (liver 4 cms and spleen 3 cms below the Costa! margin). There were no
neurological abnormalities except for a mild generalized hypotonia.
The laboratory investigations revealed a hemoglobin of 8 gm/dl. hematocrit of 25%, a total leukocyte
count of 13.2x109/L (with 20% polymorphs and 75% lymphocytes). The platelet count was 100x109/L.
The peripheral film showed no malarial parasites and the anemia was normocytic normochrornic. The
electrolytes were normal and there was no acidosis. The serum creatinine was 0.4 mg/dl (normal~0.1-1
mg/dl), the prothrombin time and the activated partial thromboplastin time were both normal. The
reticulocyte count was 1.4%, glucose-6-phosphate dehydrogenase was not deficient and the serum
lerritin was 55 ng/rnl (normal=7-200 ng/ml).
The serum calcium and phosphorus were 8 mg/dl (normal= 8.1-10.1 mg/dl) and 1 rng/dl (normal=4-5.3
mg/dl) respectively and the alkaline phosphatase was 2333 iu/L (normal=97 to 366 lulL). The urinary
aminoacid and sugar chromatogrpahy were inconclusive and the serum parathormonc level was 191
pg/mI (normal=12-72 pg/nil). The sweat chloride was 22 mmol/L. The total serum proteins were 5.9
grn/dl and the serum albumin was 3.9gm/dI (normal=3.2-5.0 grn/dl). Serum immunoglobulin levels
were normal excepting mildly raised levels of IgE (92 iu/ml). Several cultures were performed
including mycobacterial and PCR (polymerase chain reaction) for detection of DNA of mycobacteriurn
tuberculosis and all were negative.
Radiological survey of the bony skeleton showed severe generalized osteopenia. extensive rickets of
the thoracic cage and ends of long bones with splaying, cupping and fraying of metaphyses. No
pathological features were noted. Liver biopsy revealed normal architecture of the liver parenchyma
with no fibrosis in portal tacts and no granuloma formation. Significant extramedullary hemopoeisis
was seen in the liver. Bone trephine clearly depicted replacement of hemopoeisis by fibroblasts with
very occasional erythroid and myeloid precursors and no megakaryocytes were seen. Reticulin stain
revealed significantly increased fibrosis, findings being consistent with myelofibrosis (Figure 2).
Therapy and Clinical Course
The child was treated with antibiotics and bronchodilators. She was given oral sodium phosphorus,
intravenous calcium gluconate (later made oral) and oral aiphacalcidiol in the dosage of 0.25 ug daily;
After 12 weeks of therapy, there was a complete regression of hepatosplenomegaly with normalization
of complete blood count and serum alkaline phosphatase and a complete radiological healing of rickets.
Bone trephine at that time revealed a cellular specimen containing all the hemopoetic precursor cells
including megakaryocytes (Figure 3).
The reticulin stain showed none to minimal fibrosis (Figure 4).
Discussion 
Vitamin D is essential for normal skeletal growth in children and along with parathormone it plays a
central role in calcium and phosphorus homeostasis5. Casual exposure to sunlight is the major source
of vitamin D for most infants and children, because dietary source is poor in the underdeveloped
countries1. Recently, it has been recognized that a wide variety of tissues and cells, related or unrelated
to calcium metabolism, are target sites for 1,25-dihydroxyvitamin D3 (OH) 22 D3]. This has made
vitamin D an endocrine system acting on the gut, kidneys, bones, cells of immune system and several
other tissues6.
Vitamin D essentially increases intestinal calcium absorption, helps calcification of osteoid tissue in
bones and also stimulates stem cells in the marrow to mobilize calcium from the bones5. Non-calcemic
tissues that possess receptors for 1,25 (OH) 2 D3 respond to the hormone in different ways. Of great
and recent interest is the role of 1,25 (OH)2 D3 as a potent anti-proliferative and pro-differentiation
mediator5,7. M onocytes, marophages, activated lymphocytes, thymocytes and hemopoeitic stem cells
have a vitamin D receptor (VDR), a 50-k Da unit. There are several effects of 1,25 (OH)2 D3 on these
hemolymphopoeitic tissues: It modulates the production of a plethora of monocytes, lymphocytes and
bone marrow stromal cell products including several interleukins and cytokines8. 1,25 (OH)2 D3 is also
involved in the differentiation of myeloid linkage and stimulates fusion and differentiation of
hemopoeitic progenitors in bone marrow into several cell lines including osteoclasts which help in bone
resorption. Vitamin D is therefore essential for normal hemopoeisis and its deficiency may cause
suppression of marrow cell lines, clinically evident as anemia, neutropenia and thrombocytopenia9,10.
1,25 (OH)2 D3 also behaves as a paracrine factor in the immune system10. It has potent actions on all
the cellular components of the immune defence mechanisms and deficiency of vitamin D has long been
associated with recurrent infections9. Vitamin D analogues have been proven to have immune
modulatory activity and the proliferation of Tlymphocytes as well as release of cytokines (interleukin
2, interferon gamma, tumor necrosis factor) are suppressed by 1,25 (OH)2 D3. Therefore, there is also
an indirect inhibition of antibody production by B cells. These properties have been exploited and
applied to clinical and pre-clinical settings such as rheumatoid arthritis, psoriatic arthritis, multiple
sclerosis, diabetes mellitus type I, several cancers including leukaemias and myeloproliferative
disorders6,8.
The association of rickets and rnyelofibrosis was first described in 1 8899 and as yet its causal
association is unclear. A central role of vitamin D3 in bone marrow collagen disposition has been
claimed7,11, It is proposed that the active hormonal metabolite, 1.25 (OH), D3 inhibits formation of
fibrous tissue, mainly collagen, in the bone marrow and also enhances its degradation. The hormone
inhibits proliferation of megakaryocytes which promote collagen synthesis. Degradation of fibrous
tissue is mediated by the collagenases contained in monocytes and macrophages. Thus deficiency of
vitamin D may allow abnormal accumulation of collagen in the bone marrow11,12.
Deficiency of vitamin D stimulates secondary hyperparathyroidism which is a well recognized stimulus
for formation of fibrous tissue. Severe hyperparathyroidism not only leads to extreme bone
demineralization, but also to marked myelofibrosis with bone marrow displacement, osteosclerosis and
reduction in bone marrow cavity. This effect has been well elucidated in uremic patients13-15, and in
them parathyroidectomy alleviates that problem.
Secondary myelofibrosis in advanced rickets may therefore be the result .of severe deficiency of active
1,25 (OH)2 D3 or secondary hyperparathyroidism or perhaps both. Myelofibrosis leads to
compensatory extramedullary hemopoeisis resulting in hepatosplenomegaly. This is reversible after
therapy with vitamin D, as was shown in our patient. The case reported herein had severe rickets and
myelofibrosis which reversed after twelve weeks of the therapy with alphacalcidiol. We are inclined to
agree with other authors3 that rickets take a longer time to get treated in the severly malnourished.
We conclude that, since vitamin D deficiency is so common in our part of the world, clinicians must be
aware of its diverse functions and rare complications like myelofibrosis. Prevention of vitamin D
deficiency should be emphasized by dietary supplementation and adequate sunlight exposure.
References 
1. Atiq M, Suria A, Nizami SQ, et al. Vitamin D status of breastfed Pakistani infants. Acta Pediatr.
I998;87:737-40.
2. FraserD, Kooh SW, Sciver CR. Hypoparathyroidism as the cause of hyperammoaciduria and
phosphaluria in human vitamin D deficiency. Pediatr. Res., 1967;1:425-9.
3. Yetgin S, Ozsoy Iu S. Ruacan S. et al. Vitamin D deficiency rickets and myclofubrosis. J. Pediatr.,
1989;114:213-7.
4. Cooperberg AA, Singer OP. Reversible myelofibrosis due to vitamin D deficiency rickets. Can. Med.
Assoc. J., 1966;94:392.
5. Holick MF. Non-calcemic actions of 1,25-dihydroxyvitamin 03 and clinical applications. Bone.
1995; 17:1075-1115.
6. Deluca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr, Rev. 1998;56:54-75.
7. Manolagos SC, Yu XP, Girasole G, et al. Vitamin D and the hematolymphopoetic tissue. A 1994
update. Semin Nephrol.. 1994; 14:129. 43.
8. Muller K, Bcndtazen K. 1-25 dihydroxyvitamin D3 as a natural regulator of human immune
functions, J. Investig. Dermatol., Symp. Proc., 1996;1: 68-7 1.
9. Walka M, Daumling S, Hadorn MB, et al. Vitamin D dependent rickets type 11 with myelofibrosis
and immune dysfunction. Eur. J. Pediatr., 199 1;150:665-8.
10. Casteels K, Bouillon R, Waer M, et al. lmnmunomodulatory effects of 1,25-dihydroxyvitamin D3.
Cur. Opin Nephrol., Hypertens 1995;4:313-8.
11. McCarthy DM, Hibbin JA, Goldman JM. A role for 1-25 dihydroxyvitamin D3 in control of bone
marrow collagen disposition? Lancet, l984;1:78-80.
12. Yetgin S, Ozsoylu S. Myeloid metaplasia in vitamin D deficiency rickets. Scan. J. Hematol.,
1982:28:180-5.
13. Cundy T, Kanis JA, Earnshaw M, et al. Comp~arative effects if alphacalcidiol and
parathyroidectorny with vitamin D in hyperthyroid renal bone disease. Q. J. Med., 1986;60:659-70.
14. Barbour OL. Effect of parathyroidectomy on anemia in chronic renal failurc. Arch. Intern. Med.,
1979; 139:889-91.
15. Rao DS, Shih MS. Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on
the response to erythropoeitin in uremia. N. Engi. J. Med., 1993;328:l71-5.
